BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28667808)

  • 1. Coronary Artery Aneurysm After Bioresorbable Scaffold Implantation in a Woman With an Acute Coronary Syndrome.
    Cereda AF; Canova PA; Oreglia JA; Soriano FS
    J Invasive Cardiol; 2017 Jul; 29(7):E77-E78. PubMed ID: 28667808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter "real-world" registry.
    Imori Y; D'Ascenzo F; Gori T; Münzel T; Fabrizio U; Campo G; Cerrato E; Napp LC; Iannaccone M; Ghadri JR; Kazemian E; Binder RK; Jaguszewski M; Csordas A; Capasso P; Biscaglia S; Conrotto F; Varbella F; Garbo R; Gaita F; Erne P; Lüscher TF; Moretti C; Frangieh AH; Templin C
    Cardiol J; 2016; 23(4):374-83. PubMed ID: 27515481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-dilatation after implantation of bioresorbable everolimus- and novolimus-eluting scaffolds: an observational optical coherence tomography study of acute mechanical effects.
    Blachutzik F; Boeder N; Wiebe J; Mattesini A; Dörr O; Most A; Bauer T; Röther J; Tröbs M; Schlundt C; Achenbach S; Hamm CW; Nef HM
    Clin Res Cardiol; 2017 Apr; 106(4):271-279. PubMed ID: 27757522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical coherence tomography evaluation of overlapping everolimus-eluting bioresorbable vascular scaffold implantation guided by enhanced stent visualization system.
    Biscaglia S; Secco GG; Tumscitz C; Di Mario C; Campo G
    Int J Cardiol; 2015 Mar; 182():1-3. PubMed ID: 25590956
    [No Abstract]   [Full Text] [Related]  

  • 5. Very late scaffold thrombosis of everolimus-eluting bioresorbable scaffold following implantation in STEMI after discontinuation of dual antiplatelet therapy.
    Yahagi K; Virmani R; Kesavamoorthy B
    Cardiovasc Interv Ther; 2017 Jan; 32(1):53-55. PubMed ID: 26521263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug-eluting stents for percutaneous treatment of chronic total coronary occlusions: Technical and procedural outcomes from the GHOST-CTO registry.
    La Manna A; Chisari A; Giacchi G; Capodanno D; Longo G; Di Silvestro M; Capranzano P; Tamburino C
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):E155-E163. PubMed ID: 26756959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restenosis After Everolimus-eluting Vascular Scaffolding. Angiographic and Optical Coherence Tomography Characterization.
    Chavarría J; Suárez de Lezo J; Ojeda S; Pan M; Segura J; Mazuelos F; Espejo S; López J; Romero M; Suárez de Lezo J
    Rev Esp Cardiol (Engl Ed); 2017 Jul; 70(7):543-550. PubMed ID: 28132761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing distorted ABSORB Scaffold in left main during anomalous LMCA stenting.
    Rath PC; Reddy KC; Agarwala MK; Purohit BV
    Indian Heart J; 2015; 67(3):268-70. PubMed ID: 26138187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100.
    Boeder NF; Dörr O; Bauer T; Mattesini A; Elsässer A; Liebetrau C; Achenbach S; Hamm CW; Nef HM
    Int J Cardiol; 2017 Nov; 246():74-79. PubMed ID: 28579164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Multiple Coronary Micro Aneurysms After Bioresorbable Vascular Scaffold Implantation.
    Picard F; L'allier PL; Tanguay JF
    Can J Cardiol; 2017 Feb; 33(2):292.e9-292.e11. PubMed ID: 27876562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome After Long-segment Stenting With Everolimus-eluting Bioresorbable Scaffolds Focusing on the Concept of Overlapping Implantation.
    Wiebe J; Dörr O; Liebetrau C; Bauer T; Wilkens E; Ilstad H; Boeder N; Elsässer A; Möllmann H; Hamm CW; Nef HM
    Rev Esp Cardiol (Engl Ed); 2016 Dec; 69(12):1144-1151. PubMed ID: 28134094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and receding of a coronary artery aneurysm after implantation of a fully bioresorbable scaffold.
    Nakatani S; Ishibashi Y; Suwannasom P; Grundeken MJ; Høj Christiansen E; Onuma Y; Serruys PW;
    Circulation; 2015 Feb; 131(8):764-7. PubMed ID: 25712060
    [No Abstract]   [Full Text] [Related]  

  • 13. Implantation of bioresorbable scaffolds under guidance of optical coherence tomography: Feasibility and pilot clinical results of a systematic protocol.
    Gutiérrez-Chico JL; Cortés C; Schincariol M; Limon U; Yalcinli M; Durán-Cortés MA; Jaguszewski M
    Cardiol J; 2018; 25(4):443-458. PubMed ID: 29774520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and design of the COBRA II trial.
    Bennett J; Adriaenssens T; Desmet W; Dubois C
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):843-853. PubMed ID: 27184586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of acute expansion of bioresorbable vascular scaffolds versus metallic drug-eluting stents in different degrees of calcification: An Optical Coherence Tomography Study.
    Ming Fam J; van Der Sijde JN; Karanasos A; Felix C; Diletti R; van Mieghem N; de Jaegere P; Zijlstra F; Jan van Geuns R; Regar E
    Catheter Cardiovasc Interv; 2017 Apr; 89(5):798-810. PubMed ID: 27717119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
    Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
    JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary Artery Aneurysm After Mini-Crush Drug-Eluting Stent Technique in a Chronic Total Occlusion.
    Jurado-Román A; López-Lluva MT; Sánchez-Pérez I; Ruíz-Poveda FL
    J Invasive Cardiol; 2017 Jul; 29(7):E81-E82. PubMed ID: 28667810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent.
    Schneider VS; Skurk C; Riedel M; Abdelwahed YS; Landmesser U; Leistner DM
    Clin Res Cardiol; 2017 Jul; 106(7):557-559. PubMed ID: 28374059
    [No Abstract]   [Full Text] [Related]  

  • 19. Difference in vascular response between sirolimus-eluting- and everolimus-eluting stents in ostial left circumflex artery after unprotected left main as observed by optical coherence tomography.
    Fujino Y; Attizzani GF; Tahara S; Naganuma T; Takagi K; Yabushita H; Wang W; Tanaka K; Matsumoto T; Kawamoto H; Yamada Y; Amano S; Watanabe Y; Warisawa T; Sato T; Mitomo S; Kurita N; Ishiguro H; Hozawa K; Tsukahara T; Motosuke M; Bezerra HG; Nakamura S; Nakamura S
    Int J Cardiol; 2017 Mar; 230():284-292. PubMed ID: 28065691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary aneurysm and stent fracture following stenting of a myocardial bridge.
    Lu H; Ge L; Ge J
    Catheter Cardiovasc Interv; 2016 Jan; 87(1):E15-8. PubMed ID: 25573225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.